DalsnaFinance

INmune Bio receives MHRA alignment for RDEB therapy filing

Markets Investing.com By Investing.com 23 Jun 2026 12:24 1 min read
INmune Bio receives MHRA alignment for RDEB therapy filing

INmune Bio receives MHRA alignment for RDEB therapy filing

INmune Bio receives MHRA alignment for RDEB therapy filing

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.